electroCore (ECOR) Return on Capital Employed (2018 - 2026)
electroCore (ECOR) recorded quarterly Return on Capital Employed of 307.61% in Q1 2026, down 103.27% quarter-over-quarter from 151.33% in Q4 2025, and down 19093.0% on a YoY basis from N/an in Q1 2025.
electroCore (ECOR) Return on Capital Employed (2018 - 2026) Analysis & Trends
electroCore's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 307.61% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 19093.0% year-over-year to 307.61%; the TTM figure through Mar 2026 stood at 307.61% (down 19093.0% YoY), while the FY2025 annual figure was 159.99%, down 2685.0% from the prior year.
- Return on Capital Employed was 307.61% for Q1 2026 at electroCore, down from 151.33% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 57.3% in Q1 2022 to a low of 307.61% in Q1 2026.
- Historically, Return on Capital Employed has averaged 162.08% across 5 years, with a median of 149.81% in 2023.
- The sharpest annual moves came in 2024 and 2026: Return on Capital Employed jumped 15057 bps in 2024, then tumbled 19093 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 113.92% in 2022, then plunged by 69 bps to 193.04% in 2023, then soared by 46 bps to 104.79% in 2024, then tumbled by 44 bps to 151.33% in 2025, then slumped by 103 bps to 307.61% in 2026.
- The last three Return on Capital Employed figures came in at 307.61% (Q1 2026), 151.33% (Q4 2025), and 227.27% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | electroCore | 75,742.38 | -8.80 Mn | 8.36 Mn | -307.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -307.61% |
| Dec 31, 2025 | -151.33% |
| Sep 30, 2025 | -227.27% |
| Jun 30, 2025 | -229.67% |
| Mar 31, 2025 | -116.68% |
| Dec 31, 2024 | -104.79% |
| Sep 30, 2024 | -94.64% |
| Jun 30, 2024 | -133.61% |
| Mar 31, 2024 | -236.03% |
| Dec 31, 2023 | -193.04% |
| Sep 30, 2023 | -245.21% |
| Jun 30, 2023 | -233.93% |
| Mar 31, 2023 | -149.81% |
| Dec 31, 2022 | -113.92% |
| Sep 30, 2022 | -90.28% |
| Jun 30, 2022 | -70.26% |
| Mar 31, 2022 | -57.30% |
| Dec 31, 2021 | -50.46% |
| Sep 30, 2021 | -62.01% |
| Jun 30, 2021 | -79.94% |